Molecular characterization of canine prostaglandin G/H synthase-2 and regulation in prostatic adenocarcinoma cells in vitro

Endocrinology

Volumn 143, Issue 3, 2002, Pages 1134-1143

  Boutemmine, Djamila ^a   Bouchard, Nadine ^a   Boerboom, Derek ^a   Jones, Helen E ^b   Goff, Alan K ^a   Doré, Monique ^a   Sirois, Jean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; DACTINOMYCIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROSTAGLANDIN G H SYNTHASE 2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DNA LIBRARY; DNA SCREENING; DOG; EARLY RESPONSE GENE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME REGULATION; ENZYME STRUCTURE; GENE AMPLIFICATION; GENE INDUCTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR CLONING; MOLECULAR MODEL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SEQUENCE HOMOLOGY;

EID: 0036173665     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8695     Document Type: Article

References (60)

1. Molecular and cellular biology of prostate cancer
2. Cancer statistics 2001
3. Spread of prostatic cancer to bone
4. Changing trends in U.S. prostate cancer incidence rates
5. Family history and the risk of prostate cancer
6. Induced hyperproliferation in epithelial cells of mouse prostate by a Western-style diet
7. Dietary fat and prostate cancer: Current status
8. High grade prostatic intraepithelial neoplasia: The most likely precursor of prostate cancer
9. Molecular biology of prostatic intraepithelial neoplasia
10. Rodent models of prostate cancer
11. Transgenic and reconstitution models of prostate cancer
12. Experimental models of prostate cancer research
13. The prostatic carcinoma in laboratory animals: A bibliography survey from 1900 to 1977
14. Comparative pathology of benign prostatic hyperplasia and prostate cancer
15. Clinical and pathologic aspects of spontaneous canine prostate carcinomas: A retrospective analysis of 76 cases
16. The role of prostaglandin synthesis in prostate cancer
17. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of cancer
18. Inhibition of cyclooxygenase: A novel approach to cancer prevention
19. Cyclooxygenases: Structural, cellular, and molecular biology
20. Cyclooxygenases 1 and 2
21. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs
22. Suppression of intestinal polyposis in Apc δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
23. Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma
24. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate
25. Overexpression of cyclooxygenase-2 in human prostate adenocarcinoma
26. Expression of cyclooxygenase-2 in prostate carcinoma
27. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression
28. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer
29. Inhibitors of prostaglandin synthesis inhibit human prostate or cell invasiveness and reduce the release of matrix metalloproteinases
30. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse
31. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
32. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
33. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
34. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
35. The contributions of cyclooxygenase-2 to tumor angiogenesis
36. DNA oxidation induced by cyclooxygenase-2
37. Growth of a spontaneous canine prostatic adenocarcinoma in vivo and in vitro: Isolation and characterization of a neoplastic prostatic epithelial cell line, CPA 1
38. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
39. Molecular characterization of bovine prostaglandin G/H synthase-2 and regulation in uterine stromal cells
40. Multiple cyclooxygenases: Cloning of a mitogen-inducible form
41. Elongation factor Tu as a control gene for mRNA analysis of lung development and other differentiation and growth regulated systems
42. Human cyclooxygenase-2 cDNA
43. Molecular cloning, functional expression, and selective regulation of ovine prostaglandin H synthase-2
44. Prostaglandin E2 concentrations in naturally occurring canine cancer
45. Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2
46. Resveratol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
47. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
48. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells
49. Essential role of tumor necrosis factor-α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice
50. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells
51. Epithelial and fibroblastoid cell lines derived from the normal canine prostate. I. Separation and characterization of epithelial and stromalcomponents
52. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line
53. Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells
54. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells
55. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation
56. Prostaglandin synthase 2
57. Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1β: Involvement of p38 mitogen-activated protein kinase
58. Rapid induction of prostaglandin endoperoxide synthase in rat preovulatory follicles by luteinizing hormone and cAMP is blocked by inhibitors of transcription and translation
59. Selective degradation of early-response-gene mRNAs: Functional analyses of sequence features of the AU-rich elements